5-Bromocytosine - CAS 2240-25-7
Catalog: |
BB017578 |
Product Name: |
5-Bromocytosine |
CAS: |
2240-25-7 |
Synonyms: |
6-amino-5-bromo-1H-pyrimidin-2-one |
IUPAC Name: | 6-amino-5-bromo-1H-pyrimidin-2-one |
Description: | 5-Bromocytosine (CAS# 2240-25-7) is a useful research chemical. |
Molecular Weight: | 190.00 |
Molecular Formula: | C4H4BrN3O |
Canonical SMILES: | C1=NC(=O)NC(=C1Br)N |
InChI: | InChI=1S/C4H4BrN3O/c5-2-1-7-4(9)8-3(2)6/h1H,(H3,6,7,8,9) |
InChI Key: | QFVKLKDEXOWFSL-UHFFFAOYSA-N |
Melting Point: | 240-243 °C |
Purity: | 98 % |
Density: | 2.25 g/cm3 |
Appearance: | Light yellow amorphous powder |
MDL: | MFCD00056025 |
LogP: | 1.10810 |
GHS Hazard Statement: | H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral] |
Precautionary Statement: | P261, P264, P270, P271, P272, P280, P301+P312, P302+P352, P304+P340, P305+P351+P338, P310, P312, P321, P330, P332+P313, P333+P313, P362, P363, P403+P233, P405, and P501 |
Signal Word: | Danger |
Publication Number | Title | Priority Date |
CN-112618699-A | Reagent capable of providing interleukin 10 with effective treatment amount and antitumor application thereof | 20201231 |
WO-2021209970-A1 | Sars cov-2 spike protein construct | 20200416 |
WO-2021187392-A1 | Heteronucleic acid containing morpholino nucleic acid | 20200316 |
WO-2021183921-A1 | A rapid diagnostic test for lamp | 20200312 |
WO-2021157730-A1 | Nucleic acid drug and use thereof | 20200206 |
PMID | Publication Date | Title | Journal |
22146807 | 20120207 | DNA duplexes and triplex-forming oligodeoxynucleotides incorporating modified nucleosides forming stable and selective triplexes | Organic & biomolecular chemistry |
22311846 | 20120101 | Epigenetics of chronic rhinosinusitis and the role of the eosinophil | International forum of allergy & rhinology |
21864341 | 20110824 | Enzymatic synthesis of long double-stranded DNA labeled with haloderivatives of nucleobases in a precisely pre-determined sequence | BMC biochemistry |
22303378 | 20110101 | Epigenomics in environmental health | Frontiers in genetics |
17870212 | 20080601 | Xanthine oxidase-activated prodrugs of thymidine phosphorylase inhibitors | European journal of medicinal chemistry |
Complexity: | 208 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 188.95377 |
Formal Charge: | 0 |
Heavy Atom Count: | 9 |
Hydrogen Bond Acceptor Count: | 2 |
Hydrogen Bond Donor Count: | 2 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 188.95377 |
Rotatable Bond Count: | 0 |
Topological Polar Surface Area: | 67.5 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | -0.3 |
-
Catalog: BB038165
(2-Chloro-5-fluoro-pyridin-3-yl)-methanol
Detail
-
Catalog: BB007044
(1,10-Phenanthroline)(trifluoromethyl)copper(I)
Detail
-
Catalog: BB022403
(1,1,2,2-Tetrafluoroethoxy)benzene
Detail
-
Catalog: BB005304
(±)-Ethyl 2,3,3-trifluorobutyrate
Detail
-
Catalog: BB022758
(2-Chloro-1,1,2-trifluoroethyl)diethylamine
Detail
-
Catalog: BB033560
(2,8-Bis-trifluoromethyl-quinolin-4-yl)-pyridin-2-yl-methanol
Detail
-
Catalog: BB022772
(2,8-Bis-trifluoromethyl-quinolin-4-yl)-pyridin-2-yl-methanone
Detail
-
Catalog: BB038186
(2,2,3,3-Tetrafluoropropoxy)acetic acid
Detail
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Other Pyrimidines
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS